Severe Rhabdomyolysis in a Child With Multisystem Inflammatory Syndrome: An Autoimmune Mechanism?
| Autor: | Fiorentina Guida, Laura Greco, Luca Pierantoni, Marcello Lanari, Marianna Fabi, Daniela Di Luca |
|---|---|
| Přispěvatelé: | Fabi M., Guida F., Pierantoni L., Greco L., di Luca D., Lanari M. |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Short Communication MIS-C Autoimmunity Severity of Illness Index Rhabdomyolysis Developmental Neuroscience Severity of illness medicine Myositi Child Inflammation Mediator Myositis business.industry Late complication COVID-19 medicine.disease Rhabdomyolysi Cardiac injury Neurology Immunoglobulins Intravenou Pediatrics Perinatology and Child Health Immunology Female Neurology (clinical) business myositis Human |
| Zdroj: | Pediatric Neurology |
| Popis: | Coronavirus disease 2019 (COVID-19)–related myositis has been described as an initial presentation and as a potential late complication of COVID-19 in adults.1 In children, rhabdomyolysis has rarely been documented during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,2 , 3 without any detectable alteration in renal function or signs of multiorgan involvement. We here describe the first patient with rhabdomyolysis during multisystem inflammatory syndrome temporally related to COVID-19 (MIS-C). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|